Using Nanotechnology in Kidney Treatment

Tabark Faez Ghanm (1) , Sajjad Maytham Abbas (2) , Aya Fawzi Mutuk (3) , Baneen Ameer Maneam (4) , Salwa Aqeel Khleel (5)
(1) National University of Science and Technology/Medical Device Technology Engineering, , Iraq
(2) Al Mustaqbal University/College of science/ Department of medical physics. , Iraq
(3) Dhi-Qar university/college of Engineering/Biomedical engineering, Iraq.; , Iraq
(4) Dhi-Qar university/College of science/Physics/Medical Physics. , Iraq
(5) Dhi-Qar university/College of science/Physics/Medical Physics. , Iraq

Abstract

Glomerulonephritis (GN) is a group of inflammatory diseases characterized by glomerular injury and lesions. The causes of GN are relatively complex, and the pathogenesis is not yet clear. It may be caused by autoimmune dysfunction or may be related to multiple factors, such as genetics, infection, drugs, viruses, and the environment. GN can be divided into primary and secondary GN in terms of etiology . Common pathological types of primary GN include acute GN, crescentic GN, membranous GN, membranoproliferative GN, mesangial proliferative GN, focal segmental glomerulosclerosis (FSG), minimal change GN, IgA nephropathy (IgAN) and chronic GN. The most common types of secondary GN include diabetic nephropathy (DN) and lupus nephritis (LN). The symptoms of GN vary widely. Many patients have no special symptoms in the early stage. Some patients present with nephritic syndrome (hematuria, proteinuria, edema and hypertension), and some patients show nephrotic syndrome (hyperlipidemia, severe edema, heavy proteinuria and hypoproteinemia). Even patients with the same pathological characteristics may exhibit varying degrees of proteinuria  However, some typical clinical manifestations can correspond to specific GN. After 1–4 weeks of streptococcal infection, patients with symptoms such as edema, hypertension, and hematuria can be diagnosed with acute GN. Recurrent episodic microscopic or macroscopic hematuria is a landmark clinical feature of IgAN, which is the most common primary GN in the world .

Full text article

Generated from XML file

References

Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl J Med. (2010) 363:2434–43.

doi: 10.1056/NEJMra0912273 [DOI] [PubMed] [Google Scholar]

De Jong WH, Borm PJ. Drug delivery and nanoparticles:applications and hazards. Int J Nanomedicine. (2008) 3:133–49. doi: 10.2147/ijn.s596 [DOI] [PMC free article] [PubMed] [Google Scholar]

Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. (2007) 2:751–60. doi: 10.1038/nnano.2007.387 [DOI] [PubMed] [Google Scholar]

Xia Y, Xiong Y, Lim B, Skrabalak SE. Shape-controlled synthesis of metal nanocrystals: simple chemistry meets complex physics? Angew Chem Int Ed Engl. (2009) 48:60–103.

Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. (2018) 13:612–32.

Sood S, Maddiboyina B, Rawat P, Garg AK, Foudah AI, Alam A, et al. Enhancing the solubility of nitazoxanide with solid dispersions technique: formulation, evaluation, and cytotoxicity study. J Biomater Sci Polym Ed. (2021) 32:477–87.

Wu K, Su D, Liu J, Saha R, Wang JP. Magnetic nanoparticles in nanomedicine: a review of recent advances. Nanotechnology. (2019) 30:502003.

Vangijzegem T, Stanicki D, Laurent S. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Expert Opin Drug Deliv. (2019) 16:69–78.

Gupta TK, Budarapu PR, Chappidi SR, Paggi M, Bordas SP. Advances in carbon based Nanomaterials for bio-medical applications. Curr Med Chem. (2019) 26:6851–77.

Saleem J, Wang L, Chen C. Carbon-based Nanomaterials for cancer therapy via targeting tumor microenvironment. Adv Healthc Mater. (2018) 7:e1800525.

Rao S, Tan A, Thomas N, Prestidge CA. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases. J Control Release. (2014) 193:174–87.

ZhangM, YeowJT. Nanotechnology-basedterahertz biological sensing: a review of its current state and things to come. IEEENanotechnolMagaz2016;10(3):30-38

RheeJW,WuJC.Advancesinnanotechnologyforthemanagementofcoronaryarte disease. Trends CardiovascMed2013;23(2):39-45

OcchiuttoML, MaranhãoRC, Costa VP, KonstasAG. Nanotechnology for medicaland surgical glaucomatherapy-areview. AdvTher2020;37(1):155-199

Li Z, ShanX, Chen Z, etal. Applications of surface modification technologies in nanomedicine for deep tumor penetration. AdvSci (Weinh)2020; 8(1):2002589

Garimella R, Eltorai AE. Nanotechnology inorthopedics. Orthop2016;14(1):30-33

KubikT, Bogunia-KubikK, SugisakaM. Nanotechnologyondutyinmedicalapplica-tions.CurrPharmBiotechnol2005;6(1):17-33

CormodeDP, Skajaa T,Fayad ZA, Mulder WJ. Nanotechnology inmedical imaging: probedesignand applications. Arterioscler Thromb Vasc Biol2009;29(7):992-1000

RaffaV, VittorioO, RiggioC, CuschieriA. Progressinnanotechnologyforhealthcare. MinimInvasive TherAllied Technol2010;19(3):127-135

Vishwakarma K, Vishwakarma OP, Bhatele M. Abrief review onthe role ofnan-otechnology in medical sciences. In: KumarV, Bhatele M, eds. Proceedings of All India Seminaron BiomedicalEngineering2012(AISOBE2012): Lecture Notesin Bioengineeing Bengaluru:Springer; 2013

Keskinbora KH, Jameel MA. Nanotechnology applications and approaches in medicine:areview.JNanosciNanotechnolRes 2018;2(2):6

Quaders, LiuX, Tohk, etal Supramolecularenabled pH-triggereddrugactionattu mormicroenvironmentpotentiatesnanomedicine efficacy against glioblastoma Bio-materials 2021:267:120463

Azimzadeh M, RahaieM, Nasirizadeh N, DaneshpourM, Naderi-Manesh H. Elec-trochemical miRNA biosensors: the benefits of nanotechnology. Nanomed Res 1 2017;1(3):158-171.

BayfordR, RademacherT, Roittl, WangSX Emergingapplicationsofnanotechnology fordiagnosisandtherapyofdiseaseca review Physiol Meus2017;38(8):R183

Gupta N,Bahl 5, Bagha AK, Vaid S, Javaid M,Haleem A. Nanomedicinetechnol ogy and COVID-19outbreak: applications and challenges. Industr Integr Manag 2021:6(2):161-174.

Zhang Y, Ma S, Liu X, et al. Supramolecular assembled programmable nanomedicine as in situ cancer vaccine for cancer immunotherapy. Ady Mater 2021:33(7):2007293.

Polizu S, Savadogo O, Poulin P, Yahia LH. Applications of carbon nan-otubes-based biomaterials in biomedical nanotechnology. J Nanosci Nanotechnol 2006:6(7):1883-1004.

Huang B, Chen F,Shen Y, et al. Advances in targetedpesticides withan environ-mentally responsive controlled release by nanotechnology. Nanomaterials (Basel) 2018;8(2):102.

RenC, WangZ, Zhang X, etal. Construction of all-in-onepeptidenano medicine with photoacoustic imaging-guidedmild hyperthermia for enhanced cancer chemotherapy. Chem Eng 12021;405:127008

Zare-Zardini H, Amiri A, Shanbedi M, et al. Nanotechnology and pediatric cancer: prevention, diagnosis and treatment. Irun J Ped Hematol Oncol 2015;5(4):233-248.

McNeilSE. Nanotechnology for the biologist. JLeukocBio/2005;78(3):585-594

Singh,SinghS.PrasadS/GambhiriS Nanotechnology in medicinenndanti bacterial effect of silver nano particles Dig. Nanomater Biostr2008;3(3): 115-122

Fazal-ur-Rehman M.Nove applications of nanomaterial and nanotechnologyinmed icalsciences-areview JB asic ApplSci Res2018:8(4):1

AshrafA, Shafi WK, Haq MIU, Raina A. Dispersion stability of Nano additives inlu-bricatingoils-anoverview of mechanisms, theories and methodologies. Tribol Mater Surfinterf 2022:16(1):34-56

Ful, LiT, Yangi et al Activatablenano medicine for over cominghypoxia-induced resistanceto chemotherapyand inhibitingum or growthby inducing collaborative apoptosis and ferroptosisin solid tumors. Biomaterials 2021:268:120537

Ruggeri M, Bianchi E, Rossi S, et al. Nanotechnology-based medical devices for the treatment of chronicskin lesions: from research to the clinic. Pharmaceutica 2020;12(9):815.

Couvreur P, Vauthier C. Nanotechnology intelligent design to treat complex disease. PharmRex2006-23(7):1417-1450

JiangW,WangY,Wargo.JALangFF,KimBY.Considerationsfordesigningpreclinical cancer immunenanomedicinestudies NatNanotechnol2021;16(1):6-15

JacksonTC PataniBO EkpaDE Nanotechnologyindiagnosisareview AdsNanopar tic2017:6(3):93-102

Javaid M, Haleem A, Singh RP, Suman R.3D printingapplications for healthcare researchanddevelopment. Glob Health 12022;6(4):217-226

Cacciatore MA, Scheufele DA, Corley EA. From enabling technology to applica tions theevolutionof riskperceptionsaboutnanotechnology. Public UnderstandSci 2017:20(3):385-404.

Lin H. Datar RH. Medical applications of nanotechnology. Natl Med J India 2006;19(1):27-32

ShiJ, VotrubaAR, FarokhzadOC, Langer R. Nanotechnology indrug deliveryand tissueengineering fromdiscoverytoapplications. Nano Lett2010;10(9):3223-3230

Zhangl, QianM,CuiH, Zeng S,Wang J, ChenQ Spatiotemporal concurrentibera-tionofcytotoxinsfromdual-prodrug nanomedicine for synergisticantitumortherapy.

ACSApplMaterinterfaces2021;13(5):6053-6068 45. SahooSK, ParveenS, PandaJJ. Thepresentand Futureofmanotechnology inhuman. healthcare. Nanomedicine2007;3(1):20-31

Tarafdar J., SharmaS, RaliyaR. Nanotechnology interdisciplinary science of applications Afr.Biotechnol2013;12(3):219-226

Basavaraj KH. Nanotechnology inmedicine andrelevance todermatology, present concepts.Indian Dermatol2012;57(3):169

Banerjee HN, Verma M. Application of nanotechnology in cancer. Technol Cancer ftes Treat2008;7(2):149-154

KellerKH.Nanotechnologyandsociety../Nanoparticle Res 2007:9(1):5-10

Cheon Chan W. Zuhornd. Thefutureofnanotechnology.cross-disciplinedprogress toimprovehealthandmedicine AceChem Rex2019;52(9):2405

Sivaramakrishnan SM, Neelakantan P. Nanotechnologyin dentistry-whatdoes the future hold in store? Dentispy2014;4(2):1

RainaA, HaqMIU, Anand A, SudhanrajJ. Labrication characteristics of oils containing nano additives influencing parameters, market scenarioand advancements Inst Engindia Ser172021;102(2):575-587

Rastegari F, Hsiao YJ, Lai WY, etal. An update on mesoporous silicanano particle applications in nano medicine Pharmaceutics 2021;13(7):1067

WallaceGG, Higgins MJ, Moulton SE, Wang C. Nano bionics the impact of nanotech-nology on implantable medical bionic devices. Nano scale 2012;4(15):4327-4347

Neethirajans, ClondMA, VogtA. Medical biofilms-nanotechnology approaches. J Biomed Nanotechnol2014;10(10):2806-2827

Subedi SK. Anintroduction to nanotechnology and it simplications. Himalayan Phys 2015;5(5):78-81

KaiK Nanotechnology and medical robotics legal and ethical responsibility. Waseda BullComparatLaw2012;30:1-6

Huang, YangB, Peng Y,et al Nanomedicine-boosting tumor immunogenicity for enhance dimmuno therapy Ady Funct Mater2021;31(21):2011171

Authors

Tabark Faez Ghanm
Sajjad Maytham Abbas
Aya Fawzi Mutuk
Baneen Ameer Maneam
Salwa Aqeel Khleel
Ghanm, T. F., Abbas, S. M., Mutuk, A. F., Maneam, B. A., & Khleel, S. A. (2025). Using Nanotechnology in Kidney Treatment. Journal of Current Medical Research and Opinion, 8(8), 4419–4425. https://doi.org/10.52845/CMRO/2025/8-8-2

Article Details